Title: Brame AL, et al. Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist. Hypertension. 2015 Apr;65(4):834-40.
122384-88-7
217082-58-1
124584-08-3
217082-60-5
21215-62-3
205640-90-0
1263774-59-9 | Delgocitinib | AA01EO39 | MFCD31630732
1835705-61-7 | E3 ligase Ligand-Linker Conjugates 11 | AA01EO72 | MFCD31560481
1802148-05-5 | AZD7986 | AA01EODT | MFCD31619232
1034688-30-6 | GSK2018682 | AA01EOJO | MFCD18633078
56100-41-5 | d-Atabrine dihydrochloride | AA01EOP5 | MFCD31630800
1445751-74-5 | (1-(1-methylazepan-3-yl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | AA01EOWU | MFCD30718186
1329805-78-8 | 6aR,7,10,10aR-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol-d9 | AA01EP6N
1877243-60-1 | N-[[1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl]carbonyl]-L-valine | AA01EPFJ
1776115-10-6 | 9-[4-[(2-bromophenyl)methoxy]phenyl]-3,4,5,6,7,9-hexahydro-3,3,6,6-tetramethyl-1H-xanthene-1,8(2H)-dione | AA01EPKN
79353-39-2 | 3-(8Z,11Z)-8,11,14-pentadecatrien-1-yl-phenol | AA01EPRC